BRPI0414492A - solvato acetÈnico do dimetóxi docetaxel e seu processo de preparação - Google Patents

solvato acetÈnico do dimetóxi docetaxel e seu processo de preparação

Info

Publication number
BRPI0414492A
BRPI0414492A BRPI0414492-9A BRPI0414492A BRPI0414492A BR PI0414492 A BRPI0414492 A BR PI0414492A BR PI0414492 A BRPI0414492 A BR PI0414492A BR PI0414492 A BRPI0414492 A BR PI0414492A
Authority
BR
Brazil
Prior art keywords
docetaxel
solvate
dimethoxy
preparation process
acetylic
Prior art date
Application number
BRPI0414492-9A
Other languages
English (en)
Inventor
Eric Didier
Marc-Antoine Perrin
Original Assignee
Aventis Phama S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34224354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0414492(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Phama S A filed Critical Aventis Phama S A
Publication of BRPI0414492A publication Critical patent/BRPI0414492A/pt
Publication of BRPI0414492A8 publication Critical patent/BRPI0414492A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"SOLVATO ACETÈNICO DO DIMETóXI DOCETAXEL E SEU PROCESSO DE PREPARAçãO". A presente invenção refere-se a um solvato acetónico do dimetóxi docetaxel ou (2R,3S)-3-terc-butoxicarbonilamino-2-hidróxi-3-fenil-propionato de 4-acetóxi-2<244>-benzoilóxi-5<225>,20-epóxi-1-hidróxi-7>225>,10< 225>-dimetóxi-9oxo-tax-11-eno-13<244>-ila e sua preparação por cristalização a partir de uma solução hidroacetónica.
BRPI0414492A 2003-09-19 2004-09-16 solvato acetônico do dimetóxi docetaxel e seu processo de preparação BRPI0414492A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311016A FR2859996B1 (fr) 2003-09-19 2003-09-19 Solvat acetonique du dimethoxy docetaxel et son procede de preparation
PCT/FR2004/002344 WO2005028462A1 (fr) 2003-09-19 2004-09-16 Solvat acetonique du dimethoxy docetaxel et son procede de preparation

Publications (2)

Publication Number Publication Date
BRPI0414492A true BRPI0414492A (pt) 2006-11-14
BRPI0414492A8 BRPI0414492A8 (pt) 2019-01-15

Family

ID=34224354

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414492A BRPI0414492A8 (pt) 2003-09-19 2004-09-16 solvato acetônico do dimetóxi docetaxel e seu processo de preparação

Country Status (37)

Country Link
US (1) US7241907B2 (pt)
EP (1) EP1667986B1 (pt)
JP (1) JP5010279B2 (pt)
KR (1) KR101123588B1 (pt)
CN (1) CN100429207C (pt)
AR (1) AR045667A1 (pt)
AU (1) AU2004274212B2 (pt)
BE (1) BE2013C036I2 (pt)
BR (1) BRPI0414492A8 (pt)
CA (1) CA2539309A1 (pt)
CR (1) CR8292A (pt)
CY (2) CY1114575T1 (pt)
DK (1) DK1667986T3 (pt)
ES (1) ES2403149T4 (pt)
FR (2) FR2859996B1 (pt)
HR (1) HRP20130322T1 (pt)
HU (1) HUS1300025I1 (pt)
IL (1) IL174240A (pt)
LU (1) LU92172I2 (pt)
MA (1) MA28045A1 (pt)
ME (2) ME00054B (pt)
MX (1) MXPA06002639A (pt)
MY (1) MY136668A (pt)
NO (2) NO335997B1 (pt)
NZ (1) NZ545835A (pt)
PA (1) PA8612401A1 (pt)
PE (1) PE20050870A1 (pt)
PL (1) PL1667986T3 (pt)
PT (1) PT1667986E (pt)
RS (2) RS54614B1 (pt)
RU (1) RU2342373C2 (pt)
SI (1) SI1667986T1 (pt)
TN (1) TNSN06086A1 (pt)
TW (1) TWI382022B (pt)
UA (1) UA87115C2 (pt)
WO (1) WO2005028462A1 (pt)
ZA (1) ZA200602255B (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009533330A (ja) * 2006-03-21 2009-09-17 ドクター レディズ ラボラトリーズ リミテッド ドセタキセルの多形体およびプロセス
US7855591B2 (en) * 2006-06-07 2010-12-21 Atmel Corporation Method and system for providing a charge pump very low voltage applications
US7652522B2 (en) * 2006-09-05 2010-01-26 Atmel Corporation High efficiency low cost bi-directional charge pump circuit for very low voltage applications
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
AU2013205442B2 (en) * 2008-01-17 2016-05-12 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
JP5588983B2 (ja) 2008-08-11 2014-09-10 ウェルズ ファーゴ バンク ナショナル アソシエイション マルチアームポリマーアルカノエートコンジュゲート
FR2945211A1 (fr) 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
AU2015200149B2 (en) * 2009-10-29 2016-12-01 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
KR101712231B1 (ko) * 2009-10-29 2017-03-03 아벤티스 파마 소시에떼아노님 카바지탁셀의 신규한 항종양 용도
CA2708489A1 (en) * 2009-10-29 2011-04-29 Aventis Pharma S.A. Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012142117A1 (en) 2011-04-12 2012-10-18 Plus Chemicals Sa Solid state forms of cabazitaxel and processes for preparation thereof
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
CN103906747A (zh) 2011-10-31 2014-07-02 台湾神隆股份有限公司 卡巴他赛及其中间体的制备方法
WO2013065070A1 (en) 2011-11-01 2013-05-10 Fresenius Kabi Encology Ltd. Amorphous form of cabazitaxel and process for its preparation
ES2716799T3 (es) * 2011-11-28 2019-06-17 Fresenius Kabi Oncology Ltd Forma cristalina de cabazitaxel y proceso para la preparación de la misma
EP2791122B1 (en) 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
US9403785B2 (en) 2012-01-03 2016-08-02 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
JP2015509929A (ja) * 2012-02-10 2015-04-02 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの新規な小児への使用
US9394266B2 (en) 2012-03-08 2016-07-19 IVAX International GmbH Solid state forms of cabazitaxel and processes for preparation thereof
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
EP2880021A4 (en) 2012-07-31 2015-06-17 Yung Shin Pharm Ind Co Ltd AMORPHIC CABACITAXEL
EP2884963B1 (en) 2012-08-15 2017-12-27 Yung Shin Pharm. Ind. Co. Ltd. Stable pharmaceutical formulation of cabazitaxel
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
EP2777691A1 (en) 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
CN104277014A (zh) * 2013-07-04 2015-01-14 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
WO2016113752A2 (en) 2015-01-12 2016-07-21 Emcure Pharmaceuticals Limited Liquid formulation of cabazitaxel
JP6841772B2 (ja) * 2015-02-17 2021-03-10 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム 前立腺癌の処置におけるカバジタキセルの使用
EP3093014A1 (en) 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
EP3548497A4 (en) 2016-11-29 2020-09-02 Censa Pharmaceuticals Inc. SEPIAPTERIN POLYMORPHS AND THEIR SALTS
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
EP3675863A4 (en) 2017-09-01 2021-01-27 PTC Therapeutics MP, Inc. PHARMACEUTICAL COMPOSITIONS WITH SEPIAPTERIN AND USES THEREOF
BR112020024329A2 (pt) 2018-05-30 2021-02-23 Ptc Therapeutics Mp, Inc. composições e métodos para aumentar exposição de plasma de tetra-hidrobiopterin
MD3801536T2 (ro) 2018-05-30 2024-11-30 Ptc Therapeutics Mp Inc Administrarea sepiapterinei fără alimente pentru utilizare într-o metodă de creștere a expunerii plasmatice a sepiapterinei
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
DE4425978C1 (de) * 1994-07-22 1995-11-23 Karlsruhe Forschzent Verfahren zur Herstellung keramischer Mikrostrukturen
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
JP2002544269A (ja) * 1999-05-17 2002-12-24 ブリストル−マイヤーズ スクイブ カンパニー パクリタキセルおよびパクリタキセル類似体の製造におけるシリルエーテルの切断のための新規反応条件
RU2284328C2 (ru) * 2001-11-29 2006-09-27 Дайити Фармасьютикал Ко., Лтд. Кристаллы производных таксана и способ их получения

Also Published As

Publication number Publication date
KR20060072147A (ko) 2006-06-27
PT1667986E (pt) 2013-04-24
IL174240A0 (en) 2006-08-01
CY1114575T1 (el) 2016-10-05
MA28045A1 (fr) 2006-07-03
CA2539309A1 (fr) 2005-03-31
AU2004274212A1 (en) 2005-03-31
CR8292A (es) 2008-10-15
MXPA06002639A (es) 2006-06-05
RS20060189A (sr) 2008-06-05
NO2015013I1 (no) 2015-05-04
RU2006113122A (ru) 2006-08-27
ES2403149T3 (es) 2013-05-14
PA8612401A1 (es) 2005-08-04
HK1093340A1 (zh) 2007-03-02
LU92172I2 (fr) 2013-05-21
NZ545835A (en) 2009-10-30
ME00054B (me) 2011-02-10
MY136668A (en) 2008-11-28
US20050065138A1 (en) 2005-03-24
CN1849311A (zh) 2006-10-18
AR045667A1 (es) 2005-11-02
DK1667986T3 (da) 2013-05-06
JP5010279B2 (ja) 2012-08-29
NO20061714L (no) 2006-04-19
CY2013016I1 (el) 2018-01-10
AU2004274212B2 (en) 2010-03-04
BRPI0414492A8 (pt) 2019-01-15
BE2013C036I2 (pt) 2023-12-14
PE20050870A1 (es) 2005-11-21
RS54614B1 (sr) 2016-08-31
TNSN06086A1 (en) 2007-10-03
MEP11708A (en) 2010-06-10
JP2007505866A (ja) 2007-03-15
EP1667986B1 (fr) 2013-01-16
PL1667986T3 (pl) 2013-06-28
FR2859996B1 (fr) 2006-02-03
CY2013016I2 (el) 2018-01-10
HUS1300025I1 (hu) 2016-08-29
HRP20130322T1 (en) 2013-07-31
SI1667986T1 (sl) 2013-05-31
NO2015013I2 (no) 2015-04-22
FR13C0037I2 (fr) 2015-11-20
TWI382022B (zh) 2013-01-11
TW200524891A (en) 2005-08-01
ES2403149T4 (es) 2013-06-24
FR13C0037I1 (fr) 2013-09-08
EP1667986A1 (fr) 2006-06-14
ZA200602255B (en) 2007-07-25
KR101123588B1 (ko) 2012-03-22
RU2342373C2 (ru) 2008-12-27
UA87115C2 (ru) 2009-06-25
WO2005028462A1 (fr) 2005-03-31
US7241907B2 (en) 2007-07-10
NO335997B1 (no) 2015-04-20
LU92172I9 (pt) 2019-01-03
CN100429207C (zh) 2008-10-29
IL174240A (en) 2010-12-30
FR2859996A1 (fr) 2005-03-25

Similar Documents

Publication Publication Date Title
BRPI0414492A (pt) solvato acetÈnico do dimetóxi docetaxel e seu processo de preparação
SG155046A1 (en) Process for modifying drug crystal formation
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
PE20050081A1 (es) Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas
CL2003001087A1 (es) Compuestos derivados de amidas de 4-alquenil piperidina de indol, azaindol y relacionadas con heterociclicos, composicion farmaceutica, util para tratar una infeccion del vih.
BR0208741A (pt) Derivados de piperidina
BR0210139A (pt) Composições farmacêuticas
BR0315801A (pt) Compostos piridopirimidinona, eu processo de preparação e as composições farmacêuticas que os contêm
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
BRPI0416534A (pt) composições multiparticuladas com estabilidade melhorada
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
DE60112956T2 (de) Kristalline formen von fluvastatin sodium
ATE427943T1 (de) Verfahren zur herstellung von wasserfreien und hydratisierten pharmazeutischen wirkstoffen (apis); aus diesen hergestellte stabile pharmazeutische zusammensetzungen und anwendungen fur diese zusammensetzungen
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
SE9903894D0 (sv) Novel compounds
EA200702253A1 (ru) Фармацевтическая композиция
BR0309753A (pt) Processo para a preparação de derivados de 6-alquilideno penem
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
ATE497958T1 (de) Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften
EA200400709A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
BRPI0402223A (pt) Composição farmacêutica estável de cloridrato de dilitiazem para aplicação cutânea e processo para a sua preparação
DE602005026694D1 (de) 2-methylen-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol
BR0209065A (pt) Sulfato de composto de cefemo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07D 305/14; A61K 31/335; A61P 35/00

Ipc: C07D 305/14 (2011.01), A61K 31/335 (2011.01), A61P

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]